Jeanie Tryggestad, MD

Biography

Dr. Tryggestad’s clinical research interests are on the impact of youth onset type 2 diabetes on complications. She is a Co-Principle Investigator for the NIH funded TODAY trial in Oklahoma and served on the Comorbidity Assessment Committee.

Dr. Tryggestad’s other research interest focus on the impact of maternal diabetes on the future cardiometabolic health of the offspring and the impact of obesity and diabetes on vascular function. She has been awarded grant through the NIH to understand the impact of maternal diabetes on miRNA expression and protein regulation in infants.

Dr. Tryggestad serves as the co-director of the type 2 diabetes comprehensive clinic in youth at Oklahoma Children’s Hospital OU Health. Her clinical interests are focused on type 1 and type 2 diabetes with special focus on Native American populations. She also serves as the director of the Turner Syndrome Clinic.

Email

Jeanie-Tryggestad@ouhsc.edu

Additional Websites

• Publications
• OUHSC Profile

Research Interests:

• Type 2 diabetes in youth
• Impact of maternal diabetes on fetal programming
• Treatment Modalities in Youth Onset T2DM
• Vascular Complications in Youth Onset T2DM
• miRNA in Prediction of Beta-cell function and Microvascular Disease
• Impact of Maternal Diabetes on Future Cardiometabolic Function in Offspring
• Impact of Maternal Diabetes on Cellular Metabolism: Impact of miRNA